Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
|Articles|May 17, 2023
Meet Our Editor in Chief at APA 2023!
Author(s)Psychiatric Times Editors
Want to connect with our Editor in Chief?
Advertisement
Are you going to the
John J. Miller, MD, is Medical Director of Brain Health; Staff Psychiatrist at Seacoast Mental Health Center; Consulting Psychiatrist at Exeter Hospital; and Consulting Psychiatrist at Insight Meditation Society.
Dr Miller will be at the Psychiatric Times booth #1040 on Sunday and Monday, May 22 and 23. Stop by before, in-between, or after sessions for a chat!
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Treating PTSD Among Veterans at Risk for Suicide
2
FDA Grants Breakthrough Device Designation to NET Recovery's Device for Stimulant Use Disorder
3
Podcast: Not Always Panic. A Cardiologist and Psychiatrist on Reading a Racing Heart
4
Positive Phase 1b Results Demonstrate Clinical Proof-of-Concept for ALKS 7290 in Adults With ADHD
5